302 related articles for article (PubMed ID: 22294456)
1. Harnessing human plasmacytoid dendritic cells as professional APCs.
Tel J; van der Leun AM; Figdor CG; Torensma R; de Vries IJ
Cancer Immunol Immunother; 2012 Aug; 61(8):1279-88. PubMed ID: 22294456
[TBL] [Abstract][Full Text] [Related]
2. Plasmacytoid dendritic cell in immunity and cancer.
Mitchell D; Chintala S; Dey M
J Neuroimmunol; 2018 Sep; 322():63-73. PubMed ID: 30049538
[TBL] [Abstract][Full Text] [Related]
3. Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity.
Schettini J; Mukherjee P
Clin Dev Immunol; 2008; 2008():106321. PubMed ID: 19190769
[TBL] [Abstract][Full Text] [Related]
4. Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.
Tel J; Schreibelt G; Sittig SP; Mathan TS; Buschow SI; Cruz LJ; Lambeck AJ; Figdor CG; de Vries IJ
Blood; 2013 Jan; 121(3):459-67. PubMed ID: 23212525
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells in the tumor microenvironment: prognostic and theranostic impact.
Verneau J; Sautés-Fridman C; Sun CM
Semin Immunol; 2020 Apr; 48():101410. PubMed ID: 33011065
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells from bench to bedside and back.
Adema GJ
Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
[TBL] [Abstract][Full Text] [Related]
7. Targeting uptake receptors on human plasmacytoid dendritic cells triggers antigen cross-presentation and robust type I IFN secretion.
Tel J; Sittig SP; Blom RA; Cruz LJ; Schreibelt G; Figdor CG; de Vries IJ
J Immunol; 2013 Nov; 191(10):5005-12. PubMed ID: 24127556
[TBL] [Abstract][Full Text] [Related]
8. Tumoricidal activity of human dendritic cells.
Tel J; Anguille S; Waterborg CE; Smits EL; Figdor CG; de Vries IJ
Trends Immunol; 2014 Jan; 35(1):38-46. PubMed ID: 24262387
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells and immunotherapy for cancer.
Chang DH; Dhodapkar MV
Int J Hematol; 2003 Jun; 77(5):439-43. PubMed ID: 12841381
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell-based immunotherapy: a basic review and recent advances.
Constantino J; Gomes C; Falcão A; Neves BM; Cruz MT
Immunol Res; 2017 Aug; 65(4):798-810. PubMed ID: 28660480
[TBL] [Abstract][Full Text] [Related]
11. Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities.
Tel J; Smits EL; Anguille S; Joshi RN; Figdor CG; de Vries IJ
Blood; 2012 Nov; 120(19):3936-44. PubMed ID: 22966165
[TBL] [Abstract][Full Text] [Related]
12. Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity.
Noubade R; Majri-Morrison S; Tarbell KV
Front Immunol; 2019; 10():1014. PubMed ID: 31143179
[TBL] [Abstract][Full Text] [Related]
13. Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes.
Fu C; Peng P; Loschko J; Feng L; Pham P; Cui W; Lee KP; Krug AB; Jiang A
Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23730-23741. PubMed ID: 32879009
[TBL] [Abstract][Full Text] [Related]
14. Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?
Nierkens S; Tel J; Janssen E; Adema GJ
Trends Immunol; 2013 Aug; 34(8):361-70. PubMed ID: 23540650
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of murine dendritic cell antitumor dysfunction in aging.
Grolleau-Julius A; Abernathy L; Harning E; Yung RL
Cancer Immunol Immunother; 2009 Dec; 58(12):1935-9. PubMed ID: 19082999
[TBL] [Abstract][Full Text] [Related]
16. Human dendritic cell subsets for vaccination.
Dubsky P; Ueno H; Piqueras B; Connolly J; Banchereau J; Palucka AK
J Clin Immunol; 2005 Nov; 25(6):551-72. PubMed ID: 16380819
[TBL] [Abstract][Full Text] [Related]
17. Plasmacytoid dendritic cells capture and cross-present viral antigens from influenza-virus exposed cells.
Lui G; Manches O; Angel J; Molens JP; Chaperot L; Plumas J
PLoS One; 2009 Sep; 4(9):e7111. PubMed ID: 19771163
[TBL] [Abstract][Full Text] [Related]
18. Human plasmacytoid dendritic cells phagocytose, process, and present exogenous particulate antigen.
Tel J; Lambeck AJ; Cruz LJ; Tacken PJ; de Vries IJ; Figdor CG
J Immunol; 2010 Apr; 184(8):4276-83. PubMed ID: 20304825
[TBL] [Abstract][Full Text] [Related]
19. Antigen-presentation properties of plasmacytoid dendritic cells.
Villadangos JA; Young L
Immunity; 2008 Sep; 29(3):352-61. PubMed ID: 18799143
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells: immunobiology and cancer immunotherapy.
Ardavín C; Amigorena S; Reis e Sousa C
Immunity; 2004 Jan; 20(1):17-23. PubMed ID: 14738761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
